Literature DB >> 11737242

Hyperhomocysteinaemia and folate deficiency in human immunodeficiency virus-infected children.

M A Vilaseca1, C Sierra, C Colomé, R Artuch, C Valls, C Muñoz-Almagro, M A Vilches, C Fortuny.   

Abstract

BACKGROUND: Our aim was the detection of possible deficiencies of folate and cobalamin by the measurement of plasma total homocysteine (tHcy) in 69 human immunodeficiency virus (HIV) -infected children on antiretroviral treatment. We studied the relationship of these vitamins and methionine with tHcy values.
MATERIALS AND METHODS: Plasma tHcy was determined by high-performance liquid chromatography with fluorescence detection, folate and cobalamin by competitive protein-binding chemiluminescence, and methionine by ion exchange chromatography.
RESULTS: Significant differences were observed between tHcy concentrations in the HIV-infected patients and the reference values for children of similar ages (P < 0.0001). Folate values were significantly lower in HIV-infected children compared with our reference paediatric population (P < 0.0001), but cobalamin concentrations were similar between patients and reference values. A significantly negative correlation was found between tHcy and folate (r = - 0.596; P < 0.0001), and a significantly positive correlation between folate and the methionine : tHcy ratio (r = 0.501; P < 0.0001). Plasma tHcy was significantly higher (P = 0.008), while folate values and methionine : tHcy ratios were significantly lower (P = 0.007 and P = 0.042), in patients on protease inhibitor treatment than in patients on other antiretroviral therapies.
CONCLUSIONS: The hyperhomocysteinaemia and low methionine : tHcy ratios observed in our group of HIV-infected children are probably a consequence of the low folate values, which interfere in the remethylation of homocysteine to methionine. Patients on protease inhibitor treatment showed significantly higher plasma tHcy concentrations, and lower folate values and methionine : tHcy ratios, compared with patients on other antiretroviral therapies. Hyperhomocysteinaemia is associated with the risk of premature stroke, which may have adverse consequences in the evolution of disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737242     DOI: 10.1046/j.1365-2362.2001.00916.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

1.  Plasma Micronutrient Concentrations Are Altered by Antiretroviral Therapy and Lipid-Based Nutrient Supplements in Lactating HIV-Infected Malawian Women.

Authors:  Valerie L Flax; Linda S Adair; Lindsay H Allen; Setarah Shahab-Ferdows; Daniela Hampel; Charles S Chasela; Gerald Tegha; Eric J Daza; Amanda Corbett; Nicole L Davis; Deborah Kamwendo; Athena P Kourtis; Charles M van der Horst; Denise J Jamieson; Margaret E Bentley
Journal:  J Nutr       Date:  2015-07-08       Impact factor: 4.798

2.  Elevated homocysteine levels in human immunodeficiency virus-infected patients under antiretroviral therapy: A meta-analysis.

Authors:  Rafael Deminice; Talita Capoani Vieira Silva; Vitor Hugo Fernando de Oliveira
Journal:  World J Virol       Date:  2015-05-12

3.  Nutritional status and lipid profile of HIV-positive children and adolescents using antiretroviral therapy.

Authors:  Patricia Viganó Contri; Erica Miranda Berchielli; Marina Hjertquist Tremeschin; Bento Vidal de Moura Negrini; Roberta Garcia Salomão; Jacqueline Pontes Monteiro
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

4.  Multiple micronutrient supplementation improves vitamin B₁₂ and folate concentrations of HIV infected children in Uganda: a randomized controlled trial.

Authors:  Grace Ndeezi; James K Tumwine; Christopher M Ndugwa; Bjørn J Bolann; Thorkild Tylleskär
Journal:  Nutr J       Date:  2011-05-21       Impact factor: 3.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.